Immunobel-Pro™ is a professional formula that helps maintain healthy platelet and white blood cell counts (WBC).
Mirko Beljanski’s interest in strengthening the immune system led him to develop a natural product that stimulates the production of white blood cells (WBCs) and platelets—cells that are vital for immunity and for a healthy clotting reaction in blood.*
His work as a biochemist made him aware that DNA duplication, the first step of cell division—requires small RNA fragments that function as primers for DNA synthesis. Beljanski realized that a shortage of these RNA primers in bone marrow stem cells where WBC and platelets originate, could be a primary cause of low WBC counts (neutropenia) and low platelet counts (thrombocytopenia). He prepared short fragments of RNA in the laboratory and showed that these RNAs did indeed specifically stimulate proliferation of white blood cells and platelets.1,2*
More recently, a clinical trial at Cancer Treatment Centers of America demonstrated that these RNA fragments helped maintain normal WBCs and platelets in patients receiving chemotherapy—for which neutropenia and thrombocytopenia are common side effects.3 This is a breakthrough result that enabled the patients to complete their treatment without interruption, dose reduction, or platelet transfusion.*
Beljanski’s RNA fragments have been formulated in Immunobel-Pro™ and are now available to healthcare professionals for their patients who suffer from low WBC and platelet counts. The RNAs naturally restore normal levels of these cells without any negative side effects at all.*
DOSE ESCALATION STUDY OF AN ANTI-THROMBOCYTOPENIC AGENT IN PATIENTS WITH CHEMOTHERAPY INDUCED THROMBOCYTOPENIA. STUDY AT CANCER CENTER OF AMERICA (CTCA)
For more information about Beljanski products like Onkobel-Pro, Immunobel and Ginkgo-V, we recommend reading the book Winning the War on Cancer: The Epic Journey Towards A Natural Cure by Sylvie Beljanski.
Beljanski M, Plawecki M, Bourgarel P, Beljanski MS. Nouvelles substances (R.L.B.) actives dans la leucopoïèse et la formation des plaquettes. Bull. Acad. Nat. Méd. 1978;(162)6:475-781.
- Beljanski M. Overview: BLRs as Inducers of In Vivo Leucocyte and Platelet Genesis. Deutsche Zeitschrift für Onkologie. 1992(24)2:41-46.
- Levin RD, Daehler M, Grutsch Jf, Hall JL, Gupta D, et al. Dose escalation study of an anti-thrombocytopenic agent in patients with chemotherapy induced thrombocytopenia. BMC Cancer. 2010;10:565.
|Serving Size: 1 Unit|
|Servings per Container: 10 Units|
|Amount Per Serving||% Daily Value|
|Ribonucleic Extract of Escherichia coli K-12||40 mg|
|† Daily Value not established|
Other Ingredients: Mannitol.
For general support, take the contents of one unit twice a week and allow it to dissolve under the tongue. For those undergoing treatment with low levels of platelets and white blood cells (WBC), take 2 vials under the tongue every 2-3 days until levels return to the normal range or as recommended by your health care practitioner.
Keep out of reach of children.
If you are pregnant or nursing, have a medical condition, or are taking medication, consult your healthcare professional before using this or any supplement. Discontinue use if allergic reaction occurs.
†*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.